Delivery Order SPE2DB24D1006-SPE2DB24FCEPA

Award Date 9/20/24
Potential Completion Date 9/23/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 12.5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price of $4,558.68 and an ultimate completion date of August 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides $2,071.98 for the delivery of Ambien CR 12.5 mg tablets to the Defense Logistics Agency (DLA). The contract is a firm-fixed price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of Ambien CR 12.5 mg tablets in quantities of 100s. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,896.64 and a period of performance through January 27, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Ambien CR 6.25 mg tablets, with a ceiling value of $1,638.49 and an ultimate completion date of March 12, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,279.31 firm fixed-price contract is for the supply of Ambien CR 12.5mg tablets, with an ultimate completion date of August 2, 2024. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ambien CR 12.5 mg tablets. The contract is a firm-fixed-price, delivery order contract with a ceiling value of $1,659.74 and a period of performance through November 4, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Ambien CR 6.25 mg tablets in 100-count bottles. The $1,519.56 contract was awarded by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order with a ceiling value. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide...
This federal contract award is for the delivery of 4,566,307,114 units of Ambien CR 12.5 mg tablets in 100-count bottles, with a ceiling value of $2,855.91. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) on November 1, 2024. The contract has a period of performance through November 4, 2024 and is structured as a firm fixed-price delivery order. No set-aside designation was used...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,087.36 firm-fixed-price delivery order covers the supply of AMBIEN CR 12.5 MG TABLET 100S, with a period of performance through January 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.53 firm fixed-price delivery order is for the supply of Ambien CR 6.25 mg tablets to support military healthcare programs. The contract has an ultimate completion date of July 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB24FCEPA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ambien CR 12.5 mg tablets. The contract has a firm fixed price ceiling of $2,294.94 and a period of performance ending on September 23, 2024. This appears to be a delivery order placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. Amerisourcebergen, through its extensive supply chain capabilities, has been awarded numerous federal contracts to provide essential pharmaceutical and medical products to various defense and civilian agencies, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/20/24, 9:20 AM